Clinical Trial Update: Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of LEO 90100 Foam in Japanese subjects with psoriasis vulgaris has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LEO 90100 Foam

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2020-12-16